UDG Healthcare (LON:UDG) had its price objective raised by Peel Hunt from GBX 860 ($11.57) to GBX 880 ($11.84) in a report published on Thursday. Peel Hunt currently has an add rating on the stock.
A number of other analysts have also commented on the stock. N+1 Singer lifted their target price on shares of UDG Healthcare from GBX 770 ($10.36) to GBX 841 ($11.32) and gave the stock a hold rating in a report on Wednesday, November 1st. Jefferies Group lifted their target price on shares of UDG Healthcare from GBX 830 ($11.17) to GBX 855 ($11.51) and gave the stock a hold rating in a report on Wednesday, October 4th. Numis Securities reaffirmed a hold rating and set a GBX 765 ($10.30) target price on shares of UDG Healthcare in a report on Monday, August 14th. Liberum Capital lowered shares of UDG Healthcare to a hold rating and lowered their target price for the stock from GBX 930 ($12.52) to GBX 884 ($11.90) in a report on Monday, August 14th. Finally, Stifel Nicolaus reaffirmed a hold rating and set a GBX 815 ($10.97) target price on shares of UDG Healthcare in a report on Thursday, November 30th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company. The stock presently has a consensus rating of Hold and an average price target of GBX 826.43 ($11.12).
Shares of UDG Healthcare (LON UDG) opened at GBX 853.84 ($11.49) on Thursday. UDG Healthcare has a fifty-two week low of GBX 632.50 ($8.51) and a fifty-two week high of GBX 963 ($12.96).
The firm also recently announced a dividend, which will be paid on Monday, February 5th. Shareholders of record on Thursday, January 11th will be issued a dividend of $0.10 per share. This represents a yield of 0.84%. The ex-dividend date is Thursday, January 11th. This is a positive change from UDG Healthcare’s previous dividend of $0.04.
TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/10/udg-healthcare-udg-price-target-raised-to-gbx-880.html.
About UDG Healthcare
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.